Carcinosarcoma
MONDO:0002928A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.
Also known as: carcinosarcoma, carcinosarcoma, malignant, malignant mixed Mullerian tumour, malignant mixed mesodermal (mullerian) tumour, mesodermal mixed tumor (morphologic abnormality), mesodermal mixed tumour, mesodermal mixed tumour (morphologic abnormality), mixed mesodermal (mullerian) tumour
2804 clinical trials for this condition and its sub-types, 30 tagged with Carcinosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Carcinosarcoma
-
Uterine carcinosarcoma 23 trials · 32 incl. sub-types
2 sub-types
- Carcinosarcoma of the corpus uteri 13 trials
- Cervical carcinosarcoma 0 trials
-
Ovarian carcinosarcoma 18 trials
-
Fallopian tube carcinosarcoma 8 trials
-
Cancer combo trial halted early after enrolling only 5 patients
Disease control Stopped earlyThis study tested a new drug (INCB099280) combined with a standard cancer drug (axitinib) in adults with advanced solid tumors that had stopped responding to other treatments. The main goals were to check safety and see if the combination could shrink tumors. The trial was termin…
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New cancer drug BLU-222 tested in early trial – but study stopped early
Disease control Stopped earlyThis early-phase trial tested a new drug called BLU-222, alone or with other medicines, in about 50 people with advanced solid tumors (including certain breast, ovarian, and stomach cancers). The goal was to find a safe dose and see if it shrinks tumors. However, the study was te…
Phase 1 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC